- Vitamins & Supplements
- Multivitamins
- TestUdpTemporary
- Vitamins A-Z
- Mineral Supplements
- Multivitamins for Age 50+
- banner
- test 98
- Nutritional Drinks
- Adult Daily Nutrition
- Kids Nutrition (2-15 Yrs)
- For Women
- Top Deals in Supplements
- Health Food & Drinks
- Green Tea & Herbal Tea
- Herbal Juice
- Apple Cider Vinegar
- Healthy Snacks
- Protein Supplements
- Whey Protein
- Amino Acids
- Mass Gainers for testing purpose testing
- Workout Essential
- Fat Burners
Carvitop 3.125mg Tablet IR
Prescription Required
Product introduction
Carvitop 3.125mg Tablet IR is a medicine used to treat high blood pressure, heart-related chest pain (angina), and heart failure. It works by relaxing the blood vessels, so blood can flow more easily to the heart. Lowering blood pressure also helps prevent future heart attacks and stroke.
It a alpha & beta blocker.
It a alpha & beta blocker.
Uses of Carvitop Tablet IR
Benefits of Carvitop Tablet IR
In Treatment of Hypertension (high blood pressure)
Carvitop 3.125mg Tablet IR works by blocking the effects of some chemicals on your heart and blood vessels. It slows down your heart rate and helps the heart to beat with less force. This lowers your blood pressure and helps in reducing your risk of having a stroke, a heart attack, other heart problems, or kidney problems in the future. This medicine needs to be taken regularly to be effective, so keep taking it even if you feel well. Do not stop without talking to your doctor.
In Treatment of Angina
Carvitop 3.125mg Tablet IR relaxes the blood vessels so that blood can flow more easily around your body and makes sure that your heart is getting a good supply of oxygen. This makes it less likely that you will suffer chest pain caused by angina. This medicine can help increase your ability to exercise and go about your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
In Treatment of Heart failure
Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen, and other parts of your body. Carvitop 3.125mg Tablet IR makes it easier for your heart to pump blood around your body and is, therefore, effective treatment for heart failure.
This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Take it regularly and keep taking it even if you feel better.
This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Take it regularly and keep taking it even if you feel better.
Side effects of Carvitop Tablet IR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Carvitop
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carvitop Tablet IR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Carvitop 3.125mg Tablet IR is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Carvitop 3.125mg Tablet IR.
Pregnancy
CONSULT YOUR DOCTOR
Carvitop 3.125mg Tablet IR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Carvitop 3.125mg Tablet IR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Carvitop 3.125mg Tablet IR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Carvitop 3.125mg Tablet IR is safe to use in patients with kidney disease. No dose adjustment of Carvitop 3.125mg Tablet IR is recommended.
However, inform your doctor if you have any underlying kidney disease. Regular monitoring of blood pressure is recommended for dose adjustment.
However, inform your doctor if you have any underlying kidney disease. Regular monitoring of blood pressure is recommended for dose adjustment.
Liver
CAUTION
Carvitop 3.125mg Tablet IR should be used with caution in patients with liver disease. Dose adjustment of Carvitop 3.125mg Tablet IR may be needed. Please consult your doctor.
Use of Carvitop 3.125mg Tablet IR is not recommended in patients with severe liver disease.
Use of Carvitop 3.125mg Tablet IR is not recommended in patients with severe liver disease.
What if you forget to take Carvitop Tablet IR?
If you miss a dose of Carvitop 3.125mg Tablet IR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- It should be taken with food.
- Check your blood pressure 1 week after starting Carvitop 3.125mg Tablet IR, and inform your doctor if it has not improved.
- Carvitop 3.125mg Tablet IR may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- It is best to avoid drinking alcohol while taking Carvitop 3.125mg Tablet IR as it may make the side effects worse.
- Do not stop taking Carvitop 3.125mg Tablet IR suddenly as it can cause your blood pressure to rise suddenly, thereby increasing the risk of heart attack and stroke.
Fact Box
Chemical Class
Carbazole & propanol derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Alpha & beta blocker
Patient concerns
FAQs
Q. What happens when you stop taking Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR needs to be taken regularly as directed by your doctor. Suddenly stopping it may cause chest pain or heart attack. Your doctor may slowly lower your dose over a period of time before stopping it completely if required.
Q. Does Carvitop 3.125mg Tablet IR make you tired?
Yes, Carvitop 3.125mg Tablet IR may make you tired as well as dizzy. These may occur initially when you start the treatment or when the dose is increased. If you experience these symptoms you should not drive or operate machinery.
Q. Can Carvitop 3.125mg Tablet IR cause weight gain?
Yes, weight gain is a common side effect of Carvitop 3.125mg Tablet IR, but it does not occur in everyone. If you are taking Carvitop 3.125mg Tablet IR for heart failure, tell your doctor if you gain weight or have trouble breathing, as this may be a sign of fluid retention.
Q. Can Carvitop 3.125mg Tablet IR cause kidney failure?
Use of Carvitop 3.125mg Tablet IR in patients with heart failure can rarely lead to deterioration of kidney function. However, Carvitop 3.125mg Tablet IR may cause risk of kidney failure in patients with low blood pressure (systolic blood pressure less than 100 mm Hg), patients with hardening of the arteries and/or having heart disease, or already have impaired kidney function. Such patients should be closely monitored during treatment with Carvitop 3.125mg Tablet IR. Although, kidney functions return to baseline when Carvitop 3.125mg Tablet IR is stopped.
Q. Can a diabetic patient take Carvitop 3.125mg Tablet IR?
Yes, a diabetic patient can take Carvitop 3.125mg Tablet IR, provided that there is a regular check on blood glucose levels. It has been noted that in well-controlled diabetes mellitus with mild to moderate hypertension, Carvitop 3.125mg Tablet IR did not have any effect on blood glucose levels. However, it is important to know that, using Carvitop 3.125mg Tablet IR class of medicines (beta-blockers) may hide the symptoms of hypoglycemia (decrease in glucose levels), especially an increase in heartbeat or palpitations. In addition to that, Carvitop 3.125mg Tablet IR may cause worsening of hyperglycemia (increase in blood glucose levels) in patients with heart failure and diabetes. Hence, it is recommended that blood glucose should be monitored while initiating, adjusting, or discontinuing the dose of Carvitop 3.125mg Tablet IR. Inform the doctor if there is any change in blood glucose levels during Carvitop 3.125mg Tablet IR therapy.
Q. Can I take Carvitop 3.125mg Tablet IR empty stomach?
It is recommended that you take Carvitop 3.125mg Tablet IR with food, as food decreases the rate at which the medicine gets absorbed by the body. This will help to reduce the chances of orthostatic hypotension (low blood pressure which may cause dizziness or fainting when you stand up).
Q. What are the serious side effects of Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR may cause serious side effects such as fainting, shortness of breath, weight gain, swelling of the arms, hands, feet, ankles, or lower legs. Some may also experience chest pain, slow or irregular heartbeat, rash, hives, itching, and difficulty in breathing and swallowing. If you experience any of these symptoms call your doctor immediately.
Q. What if I take more than the recommended dose of Carvitop 3.125mg Tablet IR?
If you take more than the recommended dose of Carvitop 3.125mg Tablet IR you may experience slow heartbeat, dizziness, fainting, difficulty breathing, vomiting, and loss of consciousness or seizures. Contact your doctor and seek immediate medical help in a nearby hospital.
Q. Who should not take Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR should be avoided if the patient has severe heart failure and is hospitalized in the intensive care unit or require certain intravenous medications that help support circulation (inotropic medications). In addition to that, Carvitop 3.125mg Tablet IR should be avoided in patients who are prone to asthma or other breathing problems, have a slow heartbeat or irregular heartbeat, have liver problems, and are allergic to Carvitop 3.125mg Tablet IR.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Maron BA, Rocco TP. Pharmacotherapy of Congestive Heart Failure. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 801.
- Robertson D, Biaggioni I. Adrenoreceptor Antagonist Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 159-177.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 214-15.
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Carvedilol. [Updated 2018 Oct 31]. [Accessed 19 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Carvedilol. [Accessed 15 Mar. 2019] (online) Available from:
- Singh S, Preuss CV. Carvedilol. [Updated 2023 Mar 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [Accessed 12 Jun, 2023] (online) Available from:
- CiplaMed. Carvedilol [Prescribing Information]. [last Revised 29 Nov. 2019]. [Accessed 12 Jun, 2023] (online) Available from:
- Carvedilol [Prescribing Information]. Pennington, NJ: Zydus Pharm; 2023. [Accessed 12 Jun, 2023] (online) Available from:
Marketer details
Name: Docheal Pharma Pvt Ltd
Address: F-102 , Laxmi Priya Appartment, H.No :7-89/6 ,Shankar Nagar,Peerzadiguda Narapally, Hyderabad,Rangareddi,Telangana-500098
Country of origin: India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Carvitop 3.125mg Tablet IR. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Carvitop 3.125mg Tablet IR. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
In case of any issues, contact us
Email ID: [email protected]Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Lab tests offered by us
Related/Popular tests
MRP
₹30
Inclusive of all taxes
1 Strip
10.0 tablet ir in 1 strip
Cash on delivery available